Nalaganje...
Can racial disparities in optimal gout treatment be reduced? evidence from a randomized trial
There is a disproportionate burden of gout in African-Americans in the U.S. due to a higher disease prevalence and lower likelihood of receiving urate-lowering therapy (ULT), compared to Caucasians. There is an absence of strong data as to whether the response to ULT differs by race/ethnicity. BMC M...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3337326/ https://ncbi.nlm.nih.gov/pubmed/22316088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-10-15 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|